Ameritox, Ltd. (Midland, Texas), a U.S. leader in pain prescription urine drug monitoring, announced its addition of an LC-MS-MS method for detecting prescription pain medications.
Ameritox, Ltd. (Midland, Texas), a U.S. leader in pain prescription urine drug monitoring, announced its addition of an LC-MS-MS method for detecting prescription pain medications.
"We are very pleased to be among the first pain medication monitoring laboratories to invest in this advanced LC-MS-MS multiplexing technology," said Dr. James Bourland, the laboratory director at Ameritox. "By converting two high-volume confirmations from GC-MS to multiplexing LC-MS-MS, Ameritox is able to provide even faster turn-around times as well as the most accurate and reliable analytical results to physician practices, which helps them provide better patient care."
Best of the Week: What’s New in MS, 2024 Young Chemist Award Winner
March 22nd 2024This week, LCGC International published a variety of articles on the hottest topics in chromatography and beyond. Below, we’ve highlighted some of the most popular articles, according to our readers. Happy reading!
Inside the Laboratory: The Schug Group at the University of Texas at Arlington
March 22nd 2024In this edition of “Inside the Laboratory,” Kevin Schug, PhD, a full professor of chemistry at the University of Texas at Arlington, discusses his laboratory’s group work in environmental monitoring around water and soil quality near oil and gas extraction, using techniques such as liquid chromatography (LC), gas chromatography (GC), supercritical fluid chromatography (SFC), and coupling these techniques with mass spectrometry (MS).
Cloruson and Related Substances Studied Using Original Ion-Pair UHPLC Method
March 19th 2024In a recent study out of Boehringer Ingelheim Animal Health USA Inc. in North Brunswick, New Jersey, scientists investigated cloruson and its related substances using an original ion-paired reversed phase ultraperformance liquid chromatography (IP-UHPLC) method.